RSD 1000

Drug Profile

RSD 1000

Alternative Names: RSD1000

Latest Information Update: 27 Mar 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cardiome Pharma; Rhythm Search Developments
  • Developer Cardiome Pharma; Nonindustrial source; Rhythm Search Developments
  • Class Antiarrhythmics; Small molecules
  • Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 27 Mar 2003 Discontinued - Preclinical for Arrhythmias in Canada (unspecified route)
  • 27 Jun 2001 Nortran Pharmaceuticals is now called Cardiome Pharma
  • 28 Aug 1997 Preclinical development for Arrhythmias in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top